Capture

WHITE PAPERS AND CASE STUDIES

• Development And Regulation Of Veterinary Monoclonals

  Although veterinary mAbs have achieved commercial success, ongoing discussions and clinical developments surrounding them are expected to outline a clear regulatory pathway in the near future.

• Preclinical Evaluation Of Antifibrotics In COVID-Induced Fibrosis Model

  Advancing the development of effective antifibrotic therapies requires urgent investment in clinically relevant, IND-enabling preclinical models to address the growing burden of fibrotic diseases.

• The Standardization Of Plastic Luer Fittings

  This white paper aims to explore the significance and challenges of the standardization of plastic luer fittings and the importance in ensuring the quality and safety of medical devices.

• Inspection Of Injectable Products For Visible Particulates

  Examine the risks posed by particulates, the potential sources and types of particulates, and approaches to detect and measure visible particulates in injectables.

• Preclinical Evaluation Of New Antifibrotics In NASH-Induced Fibrosis Models

  Accelerate the development of antifibrotic therapies through our clinically relevant models, deep scientific expertise, and proven preclinical capabilities in this area of unmet medical need.

• Navigating The Complexities Of CGTs With Regulatory And CMC Expertise

  Review the submission process and CMC expertise which helped a biopharmaceutical company targeting a rare-disease tumor type avoid a clinical hold and advance to phase 1 clinical trials.

• RNA Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific

  Learn about the global clinical trial landscape of RNA therapy, with emphasis on trends in the Asia Pacific, and recent advancements in the field.

• Navigating The Biotech Landscape Amidst Covid-19 And Beyond

  Access comprehensive insights and analysis for a deeper understanding of the biotech landscape, including optimism and challenges felt throughout 2023 and what the future could hold.

• Today And Tomorrow: WaysTo Accelerate Decentralized And Digital Trials

  Learn about the need for investment in modern technology platforms to successfully handle the influx of new data streams available in research today, as well as those coming in the future.

• Laerdal Error-Proofs Medical Kit Assembly With AI-Powered Vision Verifications

  Discover how Laerdal Medical implemented an automated kit assembly solution that enhances quality control and supports continuous improvement through real-time monitoring and visual documentation.

• Deriving Reliable Clinical Outcome Scores From Continuous DHT Data

  DHT-derived endpoints, especially percentile-based metrics, hold promise for robust, scalable measurement in clinical trials—provided they're chosen statistically and with adherence in mind.

• The Latest Trends In The Prevention And Treatment Of Cervical Cancer

  What immune checkpoint inhibitors are showing promise in cervical cancer treatments and how are advancements in treatment, paired with additional prevention strategies, improving patient outcomes?